Total Payments
$2,963
2024 Payments
$638.29
Companies
26
Transactions
154
Medicare Patients
4,920
Medicare Billing
$254,112
Payment Breakdown by Category
Food & Beverage$2,963 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,963 | 154 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $591.77 | 21 | $0 (2024) |
| AbbVie Inc. | $408.43 | 26 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $361.33 | 7 | $0 (2024) |
| Amgen Inc. | $342.01 | 18 | $0 (2023) |
| Novo Nordisk Inc | $288.92 | 19 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $121.45 | 9 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.38 | 9 | $0 (2024) |
| Lilly USA, LLC | $120.50 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $77.21 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $72.91 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $638.29 | 23 | PFIZER INC. ($373.13) |
| 2023 | $403.65 | 28 | PFIZER INC. ($133.48) |
| 2022 | $456.69 | 20 | AstraZeneca Pharmaceuticals LP ($163.05) |
| 2021 | $755.15 | 49 | AbbVie Inc. ($267.65) |
| 2020 | $355.86 | 26 | Novo Nordisk Inc ($94.57) |
| 2019 | $353.64 | 8 | AstraZeneca Pharmaceuticals LP ($155.77) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Biological | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.42 | General |
| 10/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $104.85 | General |
| Category: VACCINES | ||||||
| 10/15/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, ABRYSVO | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: VACCINES | ||||||
| 09/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 09/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: UROLOGY | ||||||
| 08/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $110.42 | General |
| Category: VACCINES | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Obesity | ||||||
| 07/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Insulin Pump | ||||||
| 07/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Respiratory | ||||||
| 07/15/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: VACCINES | ||||||
| 07/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $126.20 | General |
| Category: VACCINES | ||||||
| 04/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: PSYCHIATRY | ||||||
| 02/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Obesity | ||||||
| 02/06/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, ABRYSVO | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: VACCINES | ||||||
| 02/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 01/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Oncology | ||||||
| 01/12/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: VACCINES | ||||||
| 12/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $1.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,254 | 1,828 | $195,335 | $76,065 |
| 2022 | 21 | 1,011 | 1,357 | $142,001 | $49,637 |
| 2021 | 34 | 1,590 | 2,166 | $205,270 | $80,432 |
| 2020 | 30 | 1,065 | 1,404 | $146,316 | $47,978 |
Total Patients
4,920
Total Services
6,755
Medicare Billing
$254,112
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 291 | $69,840 | $22,811 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 91 | 91 | $14,105 | $11,414 | 80.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 103 | $15,450 | $5,591 | 36.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 32 | $12,800 | $4,314 | 33.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $5,110 | $3,956 | 77.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 45 | 49 | $3,430 | $3,361 | 98.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 35 | $7,175 | $3,237 | 45.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 52 | $7,800 | $3,197 | 41.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 53 | 65 | $5,330 | $1,886 | 35.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 115 | 211 | $2,110 | $1,772 | 84.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 105 | 159 | $11,130 | $1,635 | 14.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 98 | 125 | $9,375 | $1,631 | 17.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 52 | $1,560 | $1,529 | 98.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 16 | $3,520 | $1,422 | 40.4% |
| 77067 | Screening mammography | Office | 2023 | 16 | 16 | $4,800 | $1,418 | 29.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 22 | 22 | $3,300 | $1,379 | 41.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 106 | 168 | $4,200 | $1,271 | 30.3% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 20 | 20 | $2,200 | $1,172 | 53.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 46 | 55 | $2,860 | $905.30 | 31.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 59 | 89 | $3,115 | $847.28 | 27.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 23 | 29 | $2,262 | $428.62 | 18.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $350.00 | $343.00 | 98.0% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 17 | 59 | $1,475 | $223.14 | 15.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 28 | $1,456 | $215.54 | 14.8% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 15 | 21 | $462.00 | $65.31 | 14.1% |
About Dr. Jessica Boldwill, MD
Dr. Jessica Boldwill, MD is a Family Medicine healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2016. The National Provider Identifier (NPI) number assigned to this provider is 1437507514.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jessica Boldwill, MD has received a total of $2,963 in payments from pharmaceutical and medical device companies, with $638.29 received in 2024. These payments were reported across 154 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,963).
As a Medicare-enrolled provider, Boldwill has provided services to 4,920 Medicare beneficiaries, totaling 6,755 services with total Medicare billing of $254,112. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Athens, TX
- Active Since 05/30/2016
- Last Updated 10/08/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437507514
Products in Payments
- PREVNAR 20 (Biological) $349.38
- EVENITY (Biological) $302.11
- LINZESS (Drug) $216.65
- FARXIGA (Drug) $209.31
- BRILINTA (Drug) $125.00
- UBRELVY (Drug) $124.85
- Ozempic (Drug) $124.75
- JANUVIA (Drug) $96.02
- MOUNJARO (Drug) $90.71
- Rybelsus (Drug) $84.73
- VRAYLAR (Drug) $78.67
- XIFAXAN (Drug) $77.21
- XARELTO (Drug) $72.91
- EUCRISA (Drug) $72.53
- Kerendia (Drug) $60.92
- PREVNAR 13 (Biological) $59.21
- ELIQUIS (Drug) $49.01
- REXULTI (Drug) $48.73
- CREON (Drug) $44.04
- Vascepa (Drug) $42.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Family Medicine $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Family Medicine $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Family Medicine $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Family Medicine $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Family Medicine $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Family Medicine $11,681